Comparison of the Macintosh, King Vision®, Glidescope® and AirTraq® Laryngoscopes in Routine Airway Management
1 other identifier
interventional
86
1 country
2
Brief Summary
Failure to successfully intubate the trachea and secure the airway remains a leading cause of morbidity and mortality, in the operative \[1-2\] and emergency settings. \[3-4\]. When the concept of endotracheal intubation was developed, 100 years ago the procedure was performed blindly. Shortly thereafter, laryngoscopes were invented, allowing for direct visualization of the larynx with a viewing angle of 15 degrees \[5\]. Insufficient laryngoscopic view constitutes the main reason for difficult intubations \[6\]. Video laryngoscopes provide an improved view of the glottis, as the camera is a few millimeters away from the glottis. The use of Glidescope \[7-8\] and AirTraq \[9\] laryngoscopes has superior glottis view and ease of tracheal intubation compared with the traditional Macintosh laryngoscope. Unfortunately, the use video laryngoscopes is associated with longer time to tracheal intubation compared with the traditional techniques which be explained with the variable learning curves of the practitioners. \[10\] The King Vision video laryngoscope® (King Systems Company, a division of Consort Medical, Indianapolis, Indiana, USA) is a relative newcomer to the video laryngoscopes of devices that claim to provide the "perfect view" for intubation via use of video and digital technology. The King Vision Video laryngoscope is a two piece design. It has a reusable monitor that attaches to disposable blades. Blades are made of high quality poly-carbonate plastic and house a complementary semi-conductor (CMOS) micro camera offers a 160 degree of view and LED light source. Up to best of the authors' knowledge, there is no current published or ongoing randomized controlled comparative study of the use of King Vision laryngoscope with traditional laryngoscope and other video laryngoscopes for endotracheal intubation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_1
Started Sep 2013
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 28, 2013
CompletedFirst Posted
Study publicly available on registry
August 2, 2013
CompletedStudy Start
First participant enrolled
September 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2015
CompletedMay 14, 2015
May 1, 2015
1.5 years
July 28, 2013
May 12, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Time to tracheal intubation
the time when the investigated laryngoscope passes the central incisors to the time when the tip of the tracheal tube passed through the glottis
participants will be followed for the duration of tracheal intubation, an expected average of 60 seconds
Secondary Outcomes (6)
laryngoscopic view
participants will be followed for the duration of laryngeal exposure, an expected average of 90 seconds
ease of intubation
participants will be followed for the duration of tracheal intubation, an expected average of 60 seconds
number of intubation attempts
participants will be followed for the duration of tracheal intubation, an expected average of 60 seconds
number of optimization maneuvers
participants will be followed for the duration of tracheal intubation, an expected average of 60 seconds
duration of laryngoscopy
during laryngoscopy
- +1 more secondary outcomes
Study Arms (4)
Macintosh
PLACEBO COMPARATORtracheal intubation will be performed using a Macintosh
King Vision
ACTIVE COMPARATORtracheal intubation will be performed using a King Vision
Glidescope
ACTIVE COMPARATORtracheal intubation will be performed using a Glidescope
AirTraq
ACTIVE COMPARATORtracheal intubation will be performed using a AirTraq
Interventions
Eligibility Criteria
You may qualify if:
- American Society of Anesthesiologists physical status class I-II
- aged 18-65 years
- scheduled for elective surgery
- under general anesthesia
You may not qualify if:
- Expected or known difficult airway
- history of cervical spine injury
- history of cervical spine surgery
- previous throat surgery
- previous oral surgery
- gastro-esophageal reflux disease
- pregnancy
- need for rapid sequence induction
- emergent surgery
- body mass index higher than 35 kg/m2
- Missing incisor teeth
- Unstable hypertension
- Unstable coronary artery disease
- Asthma
- Cerbrovascular disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Dammam University
Khobar, Eastern Province, 31259, Saudi Arabia
King Fahd Hospital of the University
Khobar, Eastern Province, 31952, Saudi Arabia
Study Officials
- PRINCIPAL INVESTIGATOR
Abdulmohsen Al Ghamdi, MD
Associate Professor/Chairman of Anesthesiology
- STUDY DIRECTOR
Mohamed R El Tahan, MD
Associate Professor of Anesthesiology
- STUDY CHAIR
Alaa M Khidr, MD
Assistant Professor of Anesthesiology
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 28, 2013
First Posted
August 2, 2013
Study Start
September 1, 2013
Primary Completion
March 1, 2015
Study Completion
April 1, 2015
Last Updated
May 14, 2015
Record last verified: 2015-05